Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 41Recurrence 14Prostatic Neoplasms 3Lymphoma, Non-Hodgkin 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Vomiting 1Vascular Diseases 1Paraproteinemias 1Neoplasms 1Neoplasm Metastasis 1Nausea 1Melanoma 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Lung Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Leukemia, Plasma Cell 1Leukemia 1Immunoproliferative Disorders 1Hemostatic Disorders 1Hemorrhagic Disorders 1Hematologic Neoplasms 1Hematologic Diseases 1Carcinoma, Non-Small-Cell Lung 1Blood Coagulation Disorders 1

Interventions

dacetuzumab 2ficlatuzumab 1Vorinostat 1Tinzaparin 1Lenalidomide 1Erlotinib Hydrochloride 1Dexamethasone 1Calcium Dobesilate 1Bortezomib 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Vascular Diseases × Calcium Dobesilate × Clear all
NCT00525447 2014-10-09

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

Seagen Inc.

Phase 1 Completed
36 enrolled
LymphoidPlasma cell

Blood Coagulation Disorders, Hematologic Diseases, Hemorrhagic Disorders, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Paraproteinemias, Vascular Diseases, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡